CLINICAL TRIAL SUMMARY

MDACC Study No:NSABP-P5 (clinicaltrials.gov NCT No: NCT01011478)
Title:Statin Polyp Prevention Trial in Patients with Resected Colon Cancer
Principal Investigator:Therese B. Bevers
Treatment Agent:Rosuvastatin
Study Status:Closed
Study Description:The goal of this clinical research study is to learn if Crestor (rosuvastatin)
is able to help prevent colon polyps from forming and/or colon cancer from
returning in patients that have had colon cancer removed by surgery. Another
reason for doing this study is to learn about the side effects of rosuvastatin
when give to preven the development of polyps and new colorectal cancer.

Hide details for General InformationGeneral Information

Disease Group:Colorectum
Phase of Study:Phase III
Treatment Agents:Rosuvastatin
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:NCI
The National Surgical Adjuvant Breast and Bowel Project
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Therese B. Bevers
Dept:Clinical Cancer Prevention
For Clinical Trial Enrollment:713-745-8040
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults